NEW YORK – (AP) Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said Wednesday they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.
Pfizer's Lipitor is the world's best-selling drug, generating nearly $13 billion in 2007 sales.